NCT06182774 2026-04-14Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple MyelomaCanadian Cancer Trials GroupPhase 3 Recruiting570 enrolled